Meloxicam versus Celecoxib for Postoperative Analgesia after Total Knee Arthroplasty: Safety, Efficacy and Cost.

Amer HaffarYale A FillinghamLeigham BreckenridgeD'Andrew GursayJess H Lonner

Published in: Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2022)

Meloxicam used at higher doses (15 mg/d) does not markedly increase the risk of GI or wound complications associated with COX-1 inhibition and is less costly for multimodal analgesia after TKA.

Keyphrases

pain management
chronic pain
total knee arthroplasty
patients undergoing
ultrasound guided
postoperative pain
risk factors
surgical site infection
wound healing